Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces FDA Approval for Industry’s Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain
July 20, 2015 at 08:30 AM EDT
[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced U.S. Food and Drug Administration approval of MR-conditional labeling for the company’s Penta™ 5-column paddle lead for spinal . . . → Read More: Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces FDA Approval for Industry’s Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain Similar Articles: Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces Second Quarter 2015 Earnings Conference Call Stock Update (NYSE:STJ): St. Jude Medical Completes Acquisition of Spinal Modulation, Inc. Company Update (NYSE:STJ): St. Jude Medical Reports First Quarter 2015 Results